NCT02007655View on ClinicalTrials.gov

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

6,372

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
NonValvular Atrial Fibrillation
Interventions
DRUG

Eliquis

Trial Locations (1)

930-0194

Local Institution, Toyama

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT02007655 - Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation | Biotech Hunter | Biotech Hunter